Low-dose Interleukin-2 in Women With Unexplained Miscarriages
Status:
Recruiting
Trial end date:
2025-02-05
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate the ability of low dose IL-2 to stimulate
peripheral blood Tregs of women with unexplained repeated early spontaneous miscarriages for
development of a therapy to prevent fetal rejection by low dose IL-2.